Delve Bio
Delve Bio is on a mission to revolutionize infectious disease testing by bringing metagenomic (mNGS) testing out of the research lab and into the clinic. Founded by some of the world’s foremost experts in infectious disease, Delve Bio is ending the era of guess and test, enabling clinicians to test once and know.
Content by Delve Bio
Updated |4 min read
Closing the Diagnostic Gap in CNS Infections
mNGS supports faster diagnosis and targeted treatment in meningitis and encephalitisSponsored by
|2 min read
Earlier Use of Metagenomic Sequencing May Streamline Meningitis, Encephalitis Workups
Modeling data suggests early metagenomic sequencing could reduce unnecessary testing and shorten time to diagnosis for CNS infectionsPage 1 of 1
